tirzepatide injections for weight loss FDA Grants a New Indication Obesity Management Tirzepatide vs. Semaglutide for Weight

Effective management of T2DM is crucial to prevent complications like cardiovascular diseases, neuropathy, nephropathy, and retinopathy, which significantly impact the quality of life and healthcare costs

10.3389/fmed.2024.1410668 86 MackowiakB.FuY.MaccioniL.GaoB

S., Zhang C

For someone who needs rapid results (perhaps before a surgery or due to obesity-related health complications), standard escalation makes more sense

While bowel obstruction is not established as a recognized adverse effect in FDA labeling or clinical trials, understanding the gastrointestinal risks, warning signs, and patient populations who should avoid tirzepatide is essential for safe prescribing and monitoring